Investigating how ASAP1 affects the spread of uveal melanoma
Targeting ASAP1-Controlled Signal Pathways to Inhibit Uveal Melanoma Metastasis
This study is looking at how a protein called ASAP1 affects the spread of uveal melanoma, a type of eye cancer, to find new ways to help prevent or treat it for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10891549 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ASAP1 in the metastasis of uveal melanoma, a type of eye cancer. Researchers are exploring how ASAP1 influences cell behavior, including migration and invasion, which are critical for cancer spread. By studying these pathways, the project aims to identify potential therapeutic targets to prevent or treat metastatic disease in patients. The approach includes using laboratory models to observe the effects of manipulating ASAP1 levels on cancer cell behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with uveal melanoma, particularly those showing signs of metastasis.
Not a fit: Patients with non-melanoma eye cancers or those whose uveal melanoma is already at an advanced stage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that inhibit the spread of uveal melanoma, improving patient outcomes.
How similar studies have performed: Previous research has shown that targeting similar pathways in other cancers has led to successful treatment strategies, suggesting potential for success in this area as well.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Yoo, Jae Hyuk — University of Nebraska Medical Center
- Study coordinator: Yoo, Jae Hyuk
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.